» Articles » PMID: 30397060

Rutin Attenuates Vancomycin-Induced Nephrotoxicity by Ameliorating Oxidative Stress, Apoptosis, and Inflammation in Rats

Overview
Specialty Pharmacology
Date 2018 Nov 7
PMID 30397060
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Nephrotoxicity is the major limiting factor for the clinical use of vancomycin (VCM) for treatment of serious infections caused by multiresistant Gram-positive bacteria. This study investigated the renal protective activity of rutin in a rat model of VCM-induced kidney injury in male Wistar rats. VCM administered intraperitoneally at 200 mg/kg twice daily for 7 successive days resulted in significant elevation of blood urea nitrogen and creatinine, as well as urinary -acetyl-β-D-glucosaminidase. Coadministration of VCM with oral rutin at 150 mg/kg significantly reduced these markers of kidney damage. Rutin also significantly attenuated VCM-induced oxidative stress, inflammatory cell infiltration, apoptosis, and decreased interleukin-1β and tumor necrosis factor alpha levels (all  < 0.05 or 0.01) in kidneys. Renal recovery from VCM injury was achieved by rutin through increases in Nrf2 and HO-1 and a decrease in NF-κB expression. Our results demonstrated a protective effect of rutin on VCM-induced kidney injury through suppression of oxidative stress, apoptosis, and downregulation of the inflammatory response. This study highlights a role for oral rutin as an effective intervention to ameliorate nephrotoxicity in patients undergoing VCM therapy.

Citing Articles

Analysis of antibiotic resistance and risk factors of extended-spectrum beta-lactamases-producing Escherichia coli in hospitalized children with community-acquired urinary tract infections.

Lin Y, Peng Q, Li W, Chen B Int Urol Nephrol. 2025; .

PMID: 39948286 DOI: 10.1007/s11255-025-04417-1.


Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology.

Qi Q, Su D, Zhuang S, Yao S, Heindl L, Fan X Adv Sci (Weinh). 2025; 12(6):e2407340.

PMID: 39755928 PMC: 11809354. DOI: 10.1002/advs.202407340.


Therapeutic Drug Monitoring of Antimicrobial Drugs in Children with Cancer: A New Tool for Personalized Medicine.

Masetti R, Bossu G, Muratore E, Leardini D, Gatti M, Di Sario R Paediatr Drugs. 2024; 27(1):41-56.

PMID: 39503988 DOI: 10.1007/s40272-024-00663-5.


Anticancer Potential of Flavonoids: Their Role in Cancer Prevention and Health Benefits.

Pyo Y, Kwon K, Jung Y Foods. 2024; 13(14).

PMID: 39063337 PMC: 11276387. DOI: 10.3390/foods13142253.


Natural products for the prevention of antibiotic-associated kidney injury.

Yuan M, Briscese K, Hong T, Brunetti L Curr Opin Toxicol. 2024; 32.

PMID: 38884043 PMC: 11178348. DOI: 10.1016/j.cotox.2022.100363.


References
1.
Cantaluppi V, Quercia A, Dellepiane S, Ferrario S, Camussi G, Biancone L . Interaction between systemic inflammation and renal tubular epithelial cells. Nephrol Dial Transplant. 2014; 29(11):2004-11. DOI: 10.1093/ndt/gfu046. View

2.
Carrasco-Pozo C, Mizgier M, Speisky H, Gotteland M . Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in Caco-2 cells. Chem Biol Interact. 2012; 195(3):199-205. DOI: 10.1016/j.cbi.2011.12.007. View

3.
Liu G, Qu J, Shen X . NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim Biophys Acta. 2008; 1783(5):713-27. DOI: 10.1016/j.bbamcr.2008.01.002. View

4.
Rhodes N, Prozialeck W, Lodise T, Venkatesan N, ODonnell J, Pais G . Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats. Antimicrob Agents Chemother. 2016; 60(10):5742-51. PMC: 5038238. DOI: 10.1128/AAC.00591-16. View

5.
Pan P, Lin S, Wang Y, Chen W, Chuang Y, Wu C . Protective effects of rutin on liver injury induced by biliary obstruction in rats. Free Radic Biol Med. 2014; 73:106-16. DOI: 10.1016/j.freeradbiomed.2014.05.001. View